Neonatal transection of the infraorbital nerve increases the expression of proteins related to neuronal death in the principal sensory nucleus of the trigeminal nerve

Brain Research

Volumn 769, Issue 2, 1997, Pages 233-244

  Miller, Michael W ^a,b,c   Kuhn, Peter E ^c  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

ALZ 50; Apoptosis; c fos; Cell death; P53

Indexed keywords

MONOCLONAL ANTIBODY ALZ 50; PROTEIN P53;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; FEMALE; INFRAORBITAL NERVE; NERVE TRANSECTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS REGULATION; RAT; SENSORY NERVE; TRIGEMINAL NERVE;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; ANTIGENS; CELL DEATH; DENERVATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; NERVOUS SYSTEM PHYSIOLOGY; NEURONS; ORBIT; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, INBRED STRAINS; SENSATION; TRIGEMINAL NUCLEI; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030780151     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00713-0     Document Type: Article

References (56)

1. Al-Ghoul W.M., Miller M.W. Transient expression of Alz-50 immunoreactivity in developing rat neocortex: a marker for naturally occurring neuronal death? Brain Res. 481:1989;361-367.
2. Al-Ghoul W.M., Miller M.W. Orderly migration of neurons to the principal sensory nucleus of the trigeminal nerve of the rat. J. Comp. Neurol. 330:1993;464-475.
3. Al-Ghoul W.M., Miller M.W. Development of the principal sensory nucleus of the trigeminal nerve of the rat and evidence for a transient synaptic field in the trigeminal sensory tract. J. Comp. Neurol. 330:1993;476-490.
4. Anderson C.W. DNA damage and the DNA-activated protein kinase. Trends Biochem. Sci. 18:1993;433-437.
5. Ashwell K.W.S., Waite P.M.E. Cell death in the developing trigeminal nuclear complex of the rat. Dev. Brain Res. 63:1991;291-295.
6. Bakalkin G., Selivanova G., Yakovleva T., Kiseleva E., Kashuba E., Magnusson K.P., Szekely L., Klein G., Terenius L., Wilman K.G. p53 binds single-stranded DNA ends through the C-terminal domain and internal segments via the middle domain. Nucleic Acids Res. 23:1995;362-369.
7. Bakalkin G., Yakoleva T., Selivanova G., Magnusson K.P., Szekely L., Kiseleva E., Klein G., Terenius L., Wilman K.G. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. USA. 91:1994;413-417.
8. Baudier J., Delphin C., Grunwald D., Khochbin S., Lawrence J.J. Characterization of the tumor suppressor protein as a protein kinase C substrate and a S100β-binding protein. Proc. Natl. Acad. Sci. USA. 89:1992;11627-11931.
9. Ciechanover A., Shkedy D., Oren M., Bercovich B. Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2. J. Biol. Chem. 269:1994;9582-9589.
10. Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., Wyllie A.H. Thymocyte apoptosis induced by p53-dependent and independent pathway. Nature. 362:1993;849-852.
11. Deffie A., Wu H., Reinke V., Lozano G. The tumor suppressor p53 regulates its own transcription. Mol. Cell. Biol. 13:1993;3415-3423.
12. Elliott E.M., Mattson M.P., Vanderklish P., Lynch G., Chang I., Sapolsky R.M. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem. 61:1993;57-67.
13. Fan S., el-Diery W.S., Bae I., Freeman J., Jondie D., Bhatia K., Fornace A.J. Jr., Magrath I., Kohn K.W., O'Connor P.M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54:1994;5824-5830.
14. Fields S., Jang S.K. Presence of a potent transcription activating sequence in the p53 protein. Science. 249:1990;1046-1049.
15. Floderus S. Untersuchungen uber den Bau der menschlichen Hypophyse mit besonderer Berucksichtigung der quantitativen mikromorphologischen Verhaltnisse. Acta Pathol. Microbiol. Scand. Suppl. 153:1944;1-276.
16. Flotow H., Graves P.R., Wang A., Fiol C.J., Roeske R.W., Roach P.J. Phosphate groups as substrate determinants for casein kinase I action. J. Biol. Chem. 265:1990;14264-14269.
17. Hsu S.-M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J. Histochem. Cytochem. 29:1981;577-580.
18. Jamal S., Ziff E.B. Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo. Oncogene. 10:1995;2095-2101.
19. Kastan M.B., Zhan Q., el-Diery W., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
20. Khanna K.K., Lavin M.F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene. 8:1993;3307-3312.
21. P.E. Kuhn, M.W. Miller, An immunoprecipitation study of the relationship of p53 and the ALZ-50-positive antigen, Neurosci. Lett., submitted.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Lees-Miller S.P., Sakaquchi K., Ullrich S.J., Appella E., Anderson C.W. Human DNA-activated protein kinase phosphorylates serine 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12:1992;5041-5049.
24. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
25. Maltzman W., Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4:1984;1689-1694.
26. Martin D.P., Schmidt R.E., DiStefano P.S., Lowry O.H., Carter J.G., Johnson E.M. Jr. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106:1988;829-844.
27. Martin D.P., Wallace T.L., Johnson E.M. Jr. Cytosine arabinoside kills postmitotic neurons in a fashion resembling trophic factor deprivation: evidence that a deoxycytidine-dependent process may be required for NGF signal transduction. J. Neurosci. 10:1990;184-193.
28. 2+ influx in cultured hippocampal neurons. Neuron. 2:1990;105-117.
29. Meck D.W., Eckhart W. Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells. Mol. Cell. Biol. 8:1989;461-465.
30. Miller M.W., Al-Ghoul W.M. Numbers of neurons in the developing principal sensory nucleus of the trigeminal nerve: enhanced survival of early-generated neurons over late-generated neurons. J. Comp. Neurol. 330:1993;491-501.
31. Miller M.W., Al-Ghoul W.M., Murtaugh M. Expression of Alz-50 immunoreactivity in the developing principal sensory nucleus of the trigeminal nerve: affect of transecting the infraorbital nerve. Brain Res. 560:1991;132-138.
32. Miller M.W., Muller S.J. Structure and histogenesis of the principal sensory nucleus of the trigeminal nerve: effects of prenatal exposure to ethanol. J. Comp. Neurol. 282:1989;570-580.
33. Milne D.M., Palmer R.H., Campbell D.G., Meek D.W. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. Oncogene. 7:1992;1301-1369.
34. Milne D.M., Campbell L.E., Campbell D.G., Meck D.W. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-jun kinase, jnk-1. J. Biol. Chem. 270:1995;5511-5518.
35. Mosner J., Mummenbrauer T., Bauer C., Sczakiel G., Grosse F., Deppert W. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14:1995;4442-4449.
36. Oberosler P., Hloch P., Ramsperger U., Stahl H. p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 12:1993;2389-2396.
37. Ojeda F., Guarda M.I., Maldonado C., Folch H., Diehl H. Role of protein kinase C in thymocyte apoptosis induced by irradiation. Int. J. Radiat. Biol. 61:1992;663-667.
38. Pietenpol J.A., Tokino T., Thiagalingam S., el-Deiry W.S., Kinzler K.W., Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA. 91:1994;1998-2002.
39. Sakhi S., Bruce A., Sun N., Tocco G., Baudry M., Schreiber S.S. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA. 91:1994;7525-7529.
40. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1992.
41. Schaeffer L., Roy R., Humbert S., Moncollin V., Vermeulen W., Hoeijmakers J.H., Chambon P., Egly J.M. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science. 260:1993;58-63.
42. 2. FEBS Lett. 348:1994;317-319.
43. Shkedy D., Gonen H., Bercovich B., Ciechanover A. Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system. FEBS Lett. 348:1994;126-130.
44. Smith M.L., Chen I.-T., Zhan Q., O'Conner P.M., Fornace A.J. Jr. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene. 10:1995;1053-1059.
45. Smolen A.J., Wright L.L., Cunningham T.J. Neuron numbers in the superior cervical sympathetic ganglion of the rat: a critical comparison of methods for cell counting. J. Neurocytol. 12:1983;739-750.
46. Soussi T., de Fromental C.C., May P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene. 5:1990;945-952.
47. Takenaka I., Morin F., Seizinger B.R., Kley N. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270:1995;5405-5411.
48. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
49. Ueda K., Masliah E., Saitoh T., Bakalis S.L., Scoble H., Kosik K.S. Alz-50 recognizes a phosphorylated epitope of tau protein. J. Neurosci. 10:1990;3295-3304.
50. Valverde F., Lopez-Mascaraque L., de Carlos J.A. Distribution and morphology of Alz-50-immunoreactive cells in the developing visual cortex of kittens. J. Neurocytol. 19:1990;662-671.
51. Vincent I.J., Davies P. ATP-induced loss of Alz-50 immunoreactivity with the A68 proteins from Alzheimer brain is mediated by ubiquitin. Proc. Natl. Acad. Sci. USA. 87:1990;4840-4844.
52. Vincent I.J., Davies P. Phosphorylation characteristics of the A68 protein in Alzheimer's disease. Brain Res. 531:1990;127-135.
53. Woloschak G.E., Chang-Liu C.-M., Shearin-Jones P. Regulation of protein kinase C by ionizing radiation. Cancer Res. 50:1990;3963-3967.
54. Wolozin B.L., Scicutella A., Davies P. Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 85:1988;6202-6206.
55. Yang X., Martinez R., Le Beau J., Wiestler O., Walter G. Evolutionary expression of the neuronal form of the src protein in the brain. Proc. Natl. Acad. Sci. USA. 86:1989;4751-4755.
56. Zhan Q., Carrier F., Fornace A.J. Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13:1993;4242-4250.